TAK 165
Cell-permeable. A potent inhibitor of the human epidermal growth factor receptor 2 (HER2) tyrosine kinase (IC₅₀ = 6 nM). Displays > 4000-fold selectivity over EGFR, FGFR, PDGFR, JAK1 and Src. TAK 165 inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
48 months
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog